For: | Law S, Cohen O, Lachmann HJ, Rezk T, Gilbertson JA, Rowczenio D, Wechalekar AD, Hawkins PN, Motallebzadeh R, Gillmore JD. Renal transplant outcomes in amyloidosis. Nephrol Dial Transplant 2021;36:355-65. [PMID: 33439995 DOI: 10.1093/ndt/gfaa293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Law S, Fontana M, Gillmore JD. Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis. Cardiol Clin 2021;39:389-402. [PMID: 34247752 DOI: 10.1016/j.ccl.2021.04.010] [Cited by in F6Publishing: 2] [Reference Citation Analysis] |
2 | Gurung R, Li T. Renal Amyloidosis: Presentation, Diagnosis, and Management. The American Journal of Medicine 2022. [DOI: 10.1016/j.amjmed.2022.01.003] [Reference Citation Analysis] |
3 | Cohen OC, Blakeney IJ, Law S, Ravichandran S, Gilbertson J, Rowczenio D, Mahmood S, Sachchithanantham S, Wisniowski B, Lachmann HJ, Whelan CJ, Martinez-Naharro A, Fontana M, Hawkins PN, Gillmore JD, Wechalekar AD. The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloidosis Centre. Amyloid 2022;:1-8. [PMID: 35502644 DOI: 10.1080/13506129.2022.2070741] [Reference Citation Analysis] |